Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01165541 · ClinicalTrials.gov registry record · Phase 2
A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency
A Phase 2 study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT01165541 is a Phase 2 study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 20 participants.
The verdict
NCT01165541, a Phase 2 study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of the study is to test whether taking two medicines (quetiapine and mirtazapine) is better for helping people to decrease drinking than taking one medicine alone (quetiapine).
Interventions
- DRUG Mirtazapine
- DRUG Quetiapine fumarate extended release (Quetiapine XR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-09 |
| Est. Completion | 2012-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01165541
The ClinicalTrials.gov registry entry for NCT01165541 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mirtazapine is the first listed.
NCT01165541 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01165541 about?
NCT01165541 is a clinical study titled "A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency". The purpose of the study is to test whether taking two medicines (quetiapine and mirtazapine) is better for helping people to decrease drinking than taking one medicine alone (quetiapine).
What is the current status of trial NCT01165541?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2010-09. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01165541?
The interventions under investigation include: Mirtazapine (DRUG), Quetiapine fumarate extended release (Quetiapine XR) (DRUG).
Who is sponsoring clinical trial NCT01165541?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.